Benjamin F. McGraw III, PharmD, has been appointed as the interim executive chairman of the board of directors at Aerie Pharmaceuticals, replacing Vicente Anido Jr., PhD, the former chairman and CEO, according to a press release.
“All of our employees appreciate Vince’s leadership, which has guided us through two FDA and EMA product approvals while building a manufacturing facility and a robust pipeline of products, leaving our company in great shape for the future,” Thomas A. Mitro, president and chief operating officer at Aerie, told Healio/OSN.
Aerie intends to separate the